Medicine Supply Notification: Quetiapine 150mg, 200mg, 300mg tablets – Updated

Update: (17/07/24) changes shown in bold below


Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 150mg, 200mg, 300mg tablets

MSN/2024/070

Tier 2 – medium impact

Date of issue: 6th June 2024

  • There are limited supplies of quetiapine 150mg, 200mg and 300mg tablets until late August 2024.
  • Subject to short-term localised supply issues quetiapine 25mg, 50mg and 100mg tablets currently remain available and can support a partial increase in demand.
  • Quetiapine XL prolonged release tablets (50mg, 150mg, 200mg, 300mg, 400mg and 600mg) remain available and can support a partial increase in demand.
  • Quetiapine 20mg/ml oral suspension remains available and can support a partial increase in demand.
  • Any updates to the supply of quetiapine tablets (any strengths) will be communicated via the Medicines Supply Tool.
  • Serious Shortage Protocols (SSP) for quetiapine 150mg, 200mg and 300mg tablets were issued on 16/07/2024.

A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.

DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.

The Tool also details any changes to resupply dates and updates to the entries.

To access the Tool you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Our CEO gives a video update addressing the prolonged pause in the 2024/25 CPCF negotiations.

Click Here